Expression of Serotonin1A and Serotonin2A Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex
The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Serotonergic 5-HT1A and 5-HT2A receptors are abundantly expressed in prefrontal cortex (PFC) and are targets of atypical antipsychotic drugs. They mediate, respectively, inhibitory and excitatory actions of 5-HT. The transcripts for both receptors are largely (approximately 80%) colocalized in rat and mouse PFC, yet their quantitative distribution in pyramidal and GABAergic interneurons is unknown. We used double in situ hybridization histochemistry to estimate the proportion of pyramidal and GABAergic neurons expressing these receptor transcripts in rat PFC. The number of GABAergic interneurons (expressing GAD mRNA) was a 22% of glutamatergic neurons (expressing vGluT1 mRNA, considered as putative pyramidal neurons). 5-HT2A receptor mRNA was present in a large percentage of pyramidal neurons (from 55% in prelimbic cortex to 88% in tenia tecta), except in layer VI, where it was localized only in 30% of those neurons. 5-HT2A receptor mRNA was present in approximately 25% of GAD-containing cells except in layer VI (10%). Likewise, approximately 60% of glutamatergic cells contained the 5-HT1A receptor transcript. We also found that approximately 25% of GAD-expressing cells contained the 5-HT1A receptor mRNA. These data help to clarify the role of 5-HT in prefrontal circuits and shed new light to the cellular elements involved in the action of atypical antipsychotics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodents, this expression pattern has been confirmed using immunohistochemistry (203–206), light and electron microscope immunocytochemistry (203), in situ hybridization (207, 208), receptor autoradiography (209), and transgenic mice expressing EGFP under control of the 5-HT2A receptor promoter (210).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [208]
In the citing paper
“These receptors mediate, respectively, the inhibitory and excitatory actions of 5-HT on cortical neurons (108); thus these alterations may produce further functional abnormalities in the anterior cingulate cortex.”
From Functional disturbances within frontostriatal circuits across multiple childhood psychopathologies (2009) · cites this paper as [108]
In the citing paper
“amplifies 5-HT1A-R-mediated inhibition of GABAergic interneurons (Santana et al., 2004) to disinhibit glutamatergic output in downstream structures (Llado-Pelfort et al., 2012).”
From The endocannabinoid system as a target for novel anxiolytic drugs (2017) · cites this paper as Santana et al., 2004
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963 · cited 1×
“Cortical areas designated according to Paxinos and Watson (1998) and Swanson (1998).”
Azmitia, E. C., & Segal, M. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901790311 · Cited by 1,909 · cited 2×
“The prefrontal cortex receives a moderate to dense serotonergic innervation from the raphe nuclei (Azmitia and Segal, 1978; Steinbusch, 1981; Blue et al., 1988) and contains several serotonin (5-hydroxytryptamine, 5-HT) receptor subtypes, with a particularly high density of 5-HT1A and 5-HT2A receptors (Pazos and Palac…”
BackgroundBrain Maps: Structure of the Rat Brain
Swanson, L. W. (1992) · Medical Entomology and Zoology · Cited by 1,878
Pazos, A., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855 · cited 2×
“…the raphe nuclei (Azmitia and Segal, 1978; Steinbusch, 1981; Blue et al., 1988) and contains several serotonin (5-hydroxytryptamine, 5-HT) receptor subtypes, with a particularly high density of 5-HT1A and 5-HT2A receptors (Pazos and Palacios, 1985; Pazos et al., 1985; Pompeiano et al., 1992, 1994).”
BackgroundSesack, S. R., Deutch, A. Y., Roth, R. H., & Bunney, B. S. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902900205 · Cited by 1,568 · cited 2×
“Of particular interest are the many neurons of the prelimbic and infralimbic areas expressing 5-HT2A and/or 5-HT1A receptors, since these areas project to midbrain serotonergic and dopaminergic cells and influence their activity (Thierry et al., 1983; Sesack et al., 1989; Hajós et al., 1998; Peyron et al., 1998; Carr…”
BackgroundLaruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291 · cited 1×
“This effect would attenuate the presumed hyperactivity of mesolimbic dopamine neurons in schizophrenic patients (Weinberger et al., 1994; Laruelle et al., 1996).”
BackgroundThe Expression of Vesicular Glutamate Transporters Defines Two Classes of Excitatory Synapse
Fremeau, R. T., Troyer, M. D., Pahner, I., Nygaard, G. O., Tran, C. H., Reimer, R. J., Bellocchio, E. E., Fortin, D., Storm-Mathisen, J., & Edwards, R. H. (2001) · Neuron · doi:10.1016/s0896-6273(01)00344-0 · Cited by 1,265
Two genes encode distinct glutamate decarboxylases
Erlander, M. G., Tillakaratne, N. J. K., Feldblum, S., Patel, N., & Tobin, A. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90077-d · Cited by 1,213 · cited 1×
“Immunohistochemical and in situ hybridization histochemistry indicate that the majority of GABA-containing neurons in the brain co-express the genes encoding the two GAD isoforms (Erlander et al., 1991; Esclapez et al., 1993, 1994; Feldblum et al., 1993).”
BackgroundPompeiano, M., Palacios, J. M., & Mengod, G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90223-2 · Cited by 881 · cited 3×
“The distribution of cells expressing the receptor transcripts agrees well with the regional patterns of distribution of the respective mRNA and protein, as assessed autoradiographically (Pazos et al., 1985; Pompeiano et al., 1992, 1994).”
BackgroundCarr, D. B., & Sesack, S. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03864.2000 · Cited by 880 · cited 3×
“The occupancy of these pyramidal receptors by atypical antipsychotics should conceivably result in a diminished excitatory input onto mesolimbic dopaminergic neurons, innervated by prefrontal afferents (Thierry et al., 1983; Carr and Sesack, 2000).”
Background
Cited by
Items 301–400 of 546
Interleukin-6 Attenuates Serotonin 2A Receptor Signaling by Activating the JAK-STAT Pathway
Donegan, J. J., Patton, M. S., Chavera, T. S., Berg, K. A., Morilak, D. A., & Girotti, M. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.096289 · Cited by 17
“…5-HT2A receptors is thought to be excitatory at the cellular level (Gellman and Aghajanian, 1994; Puig et al., 2003), but these receptors have been localized to both excitatory pyramidal cells and inhibitory interneurons in the prefrontal cortex (Santana et al., 2004; De Almeida and Mengod, 2007).”
BackgroundSerotonin actions within the prelimbic cortex induce anxiolysis mediated by serotonin 1a receptors
Yamashita, P., Rosa, D. S., Lowry, C. A., & Zangrossi, H. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118817384 · Cited by 17
Bridging the gap between single receptor type activity and whole‐brain dynamics
Jancke, D., Herlitze, S., Kringelbach, M. L., & Deco, G. (2021) · FEBS Journal · doi:10.1111/febs.15855 · Cited by 17
Puzerey, P. A., Decker, M. J., & Galán, R. F. (2014) · Journal of Neurophysiology · doi:10.1152/jn.00031.2014 · Cited by 17
“5-HT2Rs are densely expressed in the cortex (Santana et al. 2004) and mediate excitatory neuronal responses (Araneda and Andrade 1991; Tanaka and North 1993), making them a suitable candidate.”
BackgroundLee, M.-Y., Chiang, C., Chiu, H., Chan, M., & Chen, H. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.02.006 · Cited by 17
Multiple facets of serotonergic modulation
Beyeler, A., Ju, A., Chagraoui, A., Cuvelle, L., Teixeira, M., Giovanni, G. D., & Deurwaerdère, P. D. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.02.002 · Cited by 16
μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
Salinsky, L. M., Merritt, C. R., Zamora, J. C., Giacomini, J. L., Anastasio, N. C., & Cunningham, K. A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1239159 · Cited by 16
“%) of PFC pyramidal neurons express the 5-HT 2A R (Blue et al., 1988; Miner et al., 2003; Santana et al., 2004) within layer V pyramidal neurons (Pompeiano et al., 1994; Lopez-Gimenez et al., 2001; Amargos-Bosch et al., 2004; Price et al., 2019) which affords stimulatory glutamate drive to the VTA…”
BackgroundKamińska, K., Górska, A. M., Noworyta, K., Wojtas, A., Rogóż, Z., & Gołembiowska, K. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.04.009 · Cited by 16
Psychiatric Disorders - Worldwide Advances
Uehara, T. (2011) · InTech eBooks · doi:10.5772/1289 · Cited by 16
The effect of low-dose psilocybin on brain neurotransmission and rat behavior
Bysiek, A., Wojtas, A., Szpręgiel, I., Wawrzczak‐Bargieła, A., Maćkowiak, M., & Gołembiowska, K. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111347 · Cited by 15
Newman‐Tancredi, A., Varney, M. A., & McCreary, A. C. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2514-y · Cited by 15
Miquel-Rio, L., Sarriés-Serrano, U., Sancho‐Alonso, M., Florensa-Zanuy, E., Paz, V., Ruiz‐Bronchal, E., Manashirov, S., Campa, L., Pilar-Cuéllar, F., & Bortolozzi, A. A. (2024) · iScience · doi:10.1016/j.isci.2024.109787 · Cited by 15
“52,53 Next, we performed microdialysis experiments in the mPFC, which is strongly innervated by DR 5-HT neurons, 54,55 to examine whether local ERS translates into changes in forebrain 5-HT neurotransmission (Figure 3A).”
Mizoguchi, K., Kushida, H., Kanno, H., Igarashi, Y., Nishimura, H., Ikarashi, Y., & Kase, Y. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.10.015 · Cited by 15
“These interpretations are acceptable because neurotransmitter receptors recognized by GM, i.e., 5-HT1A receptors and 5-HT2A receptors, were previously shown to be distributed in the neurons of the prefrontal cortical region and DR (Santana et al., 2004; Díaz-Mataix et al., 2005).”
BackgroundAnatomical relationships between serotonin 5-HT2A and dopamine D2 receptors in living human brain
Ishii, T., Kimura, Y., Ichise, M., Takahata, K., Kitamura, S., Moriguchi, S., Kubota, M., Zhang, M.-R., Yamada, M., Higuchi, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189318 · Cited by 15
Adem, A., Madjid, N., Stiedl, O., Bonito-Oliva, A., Konradsson‐Geuken, Å., Holst, S., Fisone, G., & Ögren, S. O. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.03.007 · Cited by 15
The 5-HT1A Receptor: A Signaling Hub Linked to Emotional Balance
Chattopadhyay, A. (2007) · CRC Press eBooks · doi:10.1201/9781420005752-12 · Cited by 15
Massé, F., Hascoët, M., & Bourin, M. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.11.002 · Cited by 15
Synaptic Interactions Between Serotonergic and Dopaminergic Systems in Parkinson’s Disease
Marino, G., Campanelli, F., Natale, G., Carluccio, M. D., Servillo, F., Ghiglieri, V., & Calabresi, P. (2025) · Current Neuropharmacology · doi:10.2174/011570159x336597241217062042 · Cited by 14
“In the cortex, most postsynaptic 5-HT 1A Rs are expressed in glutamatergic neurons and located in the soma, the initial segment [93, 94], and dendrites [95, 96].”
Meccia, J., Lopez, J., & Bagot, R. C. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06297-0 · Cited by 14
“PFC GABAergic INs provide local inhibition to PNs via dendritic, somatic, and axonal synapses (Santana 2004; Lladó-Pelfort et al.”
BackgroundTherapeutic potential of CBD in Autism Spectrum Disorder
Pedrazzi, J. F. C., Hassib, L., Ferreira, F. R., Hallak, J. E. C., Del-Bel, E., & Crippa, J. A. S. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.05.002 · Cited by 14
Sharp, T. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70081-3 · Cited by 14
Serotonin 1 A auto‐receptors are not sufficient to modulate anxiety in mice
Piszczek, Ł., Schlax, K., Wyrzykowska, A., Piszczek, A., Audero, E., & Gross, C. T. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12260 · Cited by 14
“In addition, forebrain Htr1a hetero-receptors are expressed on both pyramidal cells and interneurons (Aznar et al., 2003; Santana et al., 2004; Palchaudhuri & Fl€ugge, 2005; De Almeida & Mengod, 2008; and the previously reported manipulations of Htr1a forebrain expression with the Camk2a promoter…”
BackgroundMeunier, C. N. J., Cancela, J., & Fossier, P. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.09.025 · Cited by 14
“In the PFC, 5-HT1ARs are expressed at high density (Santana et al., 2004) with specific localizations on GABAergic interneurons and on pyramidal neurons (Díaz-Mataix et al.”
BackgroundThe 5-HT 1A Receptor: A Signaling Hub Linked to Emotional Balance
Banerjee, P., Kanjilal, B., & Mehta, M. (2007) · Frontiers in neuroscience · doi:10.1201/9781420005752.ch7 · Cited by 14
Cellular Effects of Serotonin in the CNS
Andrade, R., & Beck, S. G. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70080-1 · Cited by 14
G protein-coupled receptors as targets for transformative neuropsychiatric therapeutics
Schmitz, G. P., & Roth, B. L. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00397.2022 · Cited by 13
Tejeda-Martínez, A. R., Ramos-Molina, A. R., Rubalcava, P. A. B., & Flores-Soto, M. E. (2024) · Medicine · doi:10.1097/md.0000000000038943 · Cited by 13
Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review
Erkizia-Santamaría, I., Horrillo, I., Meana, J. J., & Ortega, J. E. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111249 · Cited by 13
“As demonstrated in rat brain, 5HT2AR are primarily expressed in cortical pyramidal glutamatergic projection neurons, localised at apical dendrites, but also in GABAergic interneurons (Santana et al., 2004).”
Purple, R. J., Gupta, R., Thomas, C. W., Golden, C. T., Palomero‐Gallagher, N., Carhart-Harris, R. L., Froudist‐Walsh, S., & Jones, M. W. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03182-y · Cited by 13
Nothing Tastes as Good as Skinny Feels: the Neurobiology of Anorexia Nervosa
Kaye, W. H., Wierenga, C. E., Bailer, U. F., Simmons, A. N., & Bischoff‐Grethe, A. (2014) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.120413 · Cited by 13
Ratajczak, P., Kus, K., Zaprutko, T., Szczepański, M., Rusowicz, S., & Nowakowska, E. (2019) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2019-002 · Cited by 13
“…et al., 2000; Santana et al., 2004), ac‑ tivation of 5‑HT1B receptors (VOR) (Tatarczyńska et al., 2004), inhibition of 5‑HT2A and 5‑HT2C receptors (FLU) (Santana et al., 2004, Millan, 2005), stimulation of 5‑HT4 receptor (none of the study drugs shows such effects) (Warner‑Schmidt et al.,…”
BackgroundInfluentialEffects of Cannabidiol Isolated or in Association With Risperidone in an Animal Model of Autism
da Costa, M. D. A., Fernandes, G. Z., Maiochi, E., Ebs, M. F. P., Darós, F. D. S., Bolan, S. J., Costa, R. R. N., de Rezende, V. L., da Silva, G. C., de Bitencourt, R. M., et al. (2024) · Developmental Neurobiology · doi:10.1002/dneu.22955 · Cited by 12
“Finally, CBD is also an agonist of g-HT1A and -HT2A receptors, which are found in E/I neurons (Santana 2004).”
Guidolin, D., Tortorella, C., Marcoli, M., Cervetto, C., Maura, G., & Agnati, L. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168656 · Cited by 12
Tylš, F., Vejmola, Č., Koudelka, V., Piorecká, V., Kadeřábek, L., Bochin, M., Novák, T., Kuchař, M., Bendová, Z., Brunovský, M., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1152578 · Cited by 12
“Most likely via the same mechanism and unlike HAL, CLO induced a full reversal of DOI-evoked reduction in this frequency range (Santana et al., 2004; Celada et al., 2008).”
BackgroundDaniels, S., Mansari, M. E., Hamoudeh, R. A., & Blier, P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1276309 · Cited by 12
Boulougouris, V., Malogiannis, I. A., Lockwood, G., Zervas, I. M., & Giovanni, G. D. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3669-z · Cited by 12
“this age-related effect might represent an index of differential change in pyramidal cell loss, since most 5-Ht2A receptors are found in apical dendrites of pyramidal cell neurons and the pattern of loss of pyramidal cells matches the loss in 5-Ht2A receptors with age (Jacobs et al. 1997; Jakab and GoldmanRakic 1998;…”
BackgroundPereira, P. A., Vilela, M., Sousa, S., Rocha-Neves, J. P., Paula-barbosa, M. M., & Madeira, M. D. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.054 · Cited by 12
“, 1990; Śmiałowska, 1995), that numerous GABAergic interneurons in the mPFC express serotoninergic receptors (Santana et al., 2004), and that acetylcholine interferes with the release of most neurotransmitters and neuromodulators (Wonnacott, 1997).”
BackgroundThe Role of the Insular Cortex and Serotonergic System in the Modulation of Long-Lasting Nociception
Coffeen, U., Ramírez-Rodríguez, G. B., Simón‐Arceo, K., Mercado, F., Almanza, A., Jaimes, O., Parra-Vitela, D., Vázquez-Barreto, M., & Pellicer, F. (2024) · Cells · doi:10.3390/cells13201718 · Cited by 11
“The IC receives serotonergic inputs [41], and the major serotonin receptor subtypes expressed in this region are the metabotropic 5HT1A and 5HT2A receptors [42] and the ion channel 5HT3 [43].”
BackgroundTroca-Marín, J. A., & Geijo‐Barrientos, E. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0875-4 · Cited by 11
“subtypes 5-HT1A and 5-HT2A are the more abundant in the frontal cortex [4, 43, 49, 50, 52, 53, 55].”
BackgroundHervig, M. E.-S., Piilgaard, L., Božič, T., Alsiö, J., & Robbins, T. W. (2020) · Psychology & Neuroscience · doi:10.1037/pne0000221 · Cited by 11
“…that are robustly expressed in pyramidal neurons in the prefrontal cortex, including the OFC (Amargós-Bosch et al., 2004; Santana & Artigas, 2017; Santana, Bortolozzi, Serrats, Mengod, & Artigas, 2004), and predominantly in glutamatergic cells (AmargósBosch et al., 2004; Santana et al., 2004).”
BackgroundJensen, N. (2005) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-2111 · Cited by 11
5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence
Higgins, G. A., & Sellers, E. M. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.007 · Cited by 10
Stachowicz, K., Wierońska, J. M., Domin, H., Chaki, S., & Pilc, A. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70603-x · Cited by 10
“5HT- receptors are localized presynaptically on serotonergic neurons (mainly in the raphe nucleus), where they play the role of autoreceptors regulating the release of serotonin [35].”
Backgroundvan den Munkhof, H. E., Arnt, J., Celada, P., & Artigas, F. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.10.034 · Cited by 10
“…thalamic nuclei, and 3) the different microcircuit composition in the thalamus -lacking GABAergic interneurons- and the PFC, where both GABAergic interneurons and pyramidal neurons express most BREX targets, such as 5-HT1A-R, 5-HT2A-R,D2-R and α1B‐adrenoceptors (Santana et al., 2004; 2009; 2012).”
BackgroundThe role of serotoninergic system in psychostimulant effects
Taracha, E. (2021) · Postępy Psychiatrii i Neurologii · doi:10.5114/ppn.2021.111939 · Cited by 10
López-Terrones, E., Celada, P., Riga, M. S., & Artigas, F. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab396 · Cited by 10
Propriétés pharmacologiques de la vortioxetine et leurs conséquences pré-cliniques
David, D. J. P., Tritschler, L., Guilloux, J., Gardier, A. M., Sánchez, C., & Gaillard, R. (2016) · L Encéphale · doi:10.1016/s0013-7006(16)30015-x · Cited by 10
Kamińska, K., Noworyta, K., Jurczak, A., Górska, A. M., Rogóż, Z., & Gołembiowska, K. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.09.010 · Cited by 10
Subtraction and division of visual cortical population responses by the serotonergic systemPreprint
Azimi, Z., Spoida, K., Barzan, R., Wollenweber, P., Mark, M. D., Herlitze, S., & Jancke, D. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/444943 · Cited by 10
“We next investigated whether the observed different suppressive components were mediated via activation of different 5-HT receptor pathways (Leysen, 2004; Santana et al., 2004; Hannon and Hoyer, 2008).”
BackgroundMansari, M. E., Hamoudeh, R. A., Daniels, S., & Blier, P. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231209235 · Cited by 9
Sex-specific modulation of the medial prefrontal cortex by glutamatergic median raphe neurons
Collins, S. A., Stinson, H. E., Himes, A., Nestor‐Kalinoski, A. L., & Ninan, I. (2023) · Science Advances · doi:10.1126/sciadv.adg4800 · Cited by 9
Early synaptic changes and reduced brain connectivity in PD-like mice with depressive phenotype
Miquel-Rio, L., Jericó-Escolar, J., Sarriés-Serrano, U., Yanes-Castilla, C., Torres‐López, M., Argibay, U., Paz, V., Casal, C., Muñoz‐Moreno, E., López-Gil, X., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01073-1 · Cited by 9
“Of note, the PFC is strongly innervated by raphe 5-HT neurons 24,25 and 5-HT dysfunction is linked to depressive disorder, also in PD 16,26 .”
Brosda, J., Müller, N., Bert, B., & Fink, H. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn5003094 · Cited by 9
Hatakama, H., Asaoka, N., Nagayasu, K., Shirakawa, H., & Kaneko, S. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108926 · Cited by 9
Tang, Z.-H., Yu, Z., Li, Q., Zhang, X., Muhetaer, K., Wang, Z., Xu, P., & Shen, H. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06366-y · Cited by 9
“According to a study using in situ hybridization, it was found that only 25% of the GABAergic interneurons in layers II–V of the mPFC expressed the 5-HT2AR mRNA (Santana et al. 2004).”
BackgroundRovira, V., & Geijo‐Barrientos, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150092 · Cited by 9
“To investigate the subtypes of serotonin receptors implicated in the latency increase induced by 5-HT, we tested the effect of agents acting on the 5-HT receptor subtypes 5-HT1A, 5-HT1B, and 5-HT2A, which are present in the neocortex [35, 49].”
BackgroundMethodTsuchida, R., Kubo, M., Shintani, N., Abe, M., Köves, K., Uetsuki, K., Kuroda, M., Hashimoto, H., & Baba, A. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.728 · Cited by 9
Bianchi, C., Marani, L., Marino, S., Barbieri, M., Nazzaro, C., Beani, L., & Siniscalchi, A. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.017 · Cited by 9
“It is generally recognized that 5-HT2A receptor activation increases the excitability of the cortical glutamatergic pyramidal neurons and GABAergic interneurons, whereas 5-HT1 activation inhibits their excitability or axonal firing (Abi-Saab et al., 1999; Amargos-Bosch et al., 2004; Barnes and Sharp, 1999; Hajos et al…”
BackgroundKatow, H., Katow, T., Abe, K., Ooka, S., Kiyomoto, M., & Hamanaka, G. (2013) · Biology Open · doi:10.1242/bio.20136882 · Cited by 9
“The dual expression of GAD and serotonin receptor in a single blastocoelar cell, as observed in the present study, is not unique to sea urchin, but instead is widely recognized in vertebrates, such as in stage 42–48 Xenopus tadpole (Huang and Moody, 1998), the prefrontal cortex of rat and primates (Jakab and Goldman-R…”
BackgroundJafari‐Sabet, M., Nemati, S., & Torab, M. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119826608 · Cited by 9
“Furthermore, there is evidence that the release of GABA in the hippocampus and other brain regions is modulated by 5-HT1A and 5-HT7 receptors (Llado-Pelfort et al., 2012; Santana et al., 2004; Tokarski et al., 2011).”
Dearnley, B., Dervinis, M., Shaw, M., & Okun, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.22.457198 · Cited by 9
“We focused on mPFC since its neurons have a high level of expression of 5-HT2AR (Santana et al., 2004; Weber and Andrade, 2010; Andrade, 2011), it is implicated in the functional connectivity changes described in human subjects and it has been a primary focus of previous in vitro research (Avesar…”
BackgroundAltered brain serotonin 5-HT1A receptor expression and function in juvenile Fmr1 knockout mice
Saraf, T. S., Chen, Y., Tyagi, R., & Canal, C. E. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109774 · Cited by 8
Olson, R. J., Bartlett, L., Sonneborn, A., Milton, R., Bretton-Granatoor, Z., Firdous, A., Harris, A. Z., & Abbas, A. I. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110030 · Cited by 8
Ali, E. H. A., Hassan, M. K., Abbas, O., E.Elmalahy, H., & Almaaty, A. A. (2020) · African Journal of Biological Sciences · doi:10.21608/ajbs.2020.133010 · Cited by 8
cis-3-Hexenol and trans-2-hexenal mixture prevents development of PTSD-like phenotype in rats
Nikaido, Y., Yamada, J., Migita, K., Shiba, Y., Furukawa, T., Nakashima, T., & Ueno, S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.10.023 · Cited by 8
Contributions of Non-Human Primates to the Understanding of Cocaine Addiction
Rafael, S., Barros, M., & Tomaz, C. A. B. (2011) · InTech eBooks · doi:10.5772/26644 · Cited by 8
“In rodents, 5-HT1A mRNA seems to be restricted to the deeper layers of the prefrontal cortex (Pompeiano et al., 1992; Santana et al., 2004) and therefore would not exert the same influence on cortical activity.”
Background5-HT1A receptor activation is necessary for 5-MeODMT-dependent potentiation of feeding inhibition
Duvvuri, V., Risbrough, V. B., Kaye, W. H., & Geyer, M. A. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.05.014 · Cited by 8
“Postsynaptic 5-HT1A and 5-HT2A receptors mediate, respectively, the direct hyperpolarizing and depolarizing actions of 5-HT on prefrontal neurons (Santana et al., 2004), which in turn project to numerous cortical and subcortical areas.”
BackgroundNeurochemical modulation of orbitofrontal cortex function
Robbins, T. W., Clark, L., Clarke, H. F., & Roberts, A. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198565741.003.0016 · Cited by 8
Hervig, M. E.-S., Zühlsdorff, K., Olesen, S. F., Phillips, B. U., Božič, T., Dalley, J. W., Cardinal, R. N., Alsiö, J., & Robbins, T. W. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06586-w · Cited by 7
Serotonergic Modulation of the Prefrontal Cortex: From Neurons to Brain Waves
Victoria, M. (2011) · InTech eBooks · doi:10.5772/25572 · Cited by 7
“…receptors, in particular 5-HT1A, 5-HT2A and 5-HT3A receptors (De Almeida & Mengod, 2007; Jakab and Goldman-Rakic, 2000; Jansson et al., 2001; Morales & Bloom, 1997; Puig et al., 2004, 2010; Santana et al., 2004; Vucurovic et al., 2010; Weber & Andrade, 2010; Willins et al., 1997) (Figure 1).”
BackgroundInfluentialSerotonergic Modulation of Cognition in Prefrontal Cortical Circuits in Major Depression
Ramírez-Mahaluf, J. P., & Compte, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809825-7.00002-x · Cited by 7
Shi, M., Tang, J., Yang, C., Guo, G., Ou, H., & Chen, W. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108838 · Cited by 7
Sun, Y., Chebolu, S., Henry, D., Lankireddy, S., & Darmani, N. A. (2022) · BMC Neuroscience · doi:10.1186/s12868-021-00686-5 · Cited by 7
“Second, MA also increases NE levels in the PFC [39] and both adrenergic ɑ2- and serotonergic 5-HT2A-receptors are enriched in layers I and V in the PFC [50, 62, 63].”
BackgroundAltered Serotonin Function in Anorexia and Bulimia Nervosa
Duvvuri, V., Bailer, U. F., & Kaye, W. H. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70107-7 · Cited by 7
The role of the glycoprotein gp130 in the serotonin mediator system in the mouse brain
Kulikov, A. V., Naumenko, V. S., Tsybko, A. S., Sinyakova, N. A., Базовкина, Д. В., & Popova, N. K. (2010) · Molecular Biology · doi:10.1134/s0026893310050171 · Cited by 7
“The avail able data suggest there is a negative interaction between 5 HT1A and 5 HT2A receptor activities, and the activation of one of them suppresses the function of the other [37–43].”
BackgroundWang, Y., Kristensen, J. L., & Kohlmeier, K. A. (2025) · Synapse · doi:10.1002/syn.70014 · Cited by 6
Zhang, Q., Wang, S., Zhang, L., Zhang, H., Qiao, H., Niu, X., & Liu, J. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1669-9 · Cited by 6
Gaucher, Q., Yger, P., & Edeline, J. (2020) · The Journal of Physiology · doi:10.1113/jp279902 · Cited by 6
“Neuromodulators target both pyramidal cells and inhibitory interneurons (acetylcholine: Metherate et al. 1992; Alitto & Dan, 2012; noradrenaline: Toussay et al. 2013; Salgado et al. 2016; serotonin: Aznar et al. 2003; Santana et al. 2004; De Almeida & Mengod, 2007; Garcı́a-Oscos et al. 2015), often with opposite effec…”
BackgroundLambe, E. K., & Aghajanian, G. K. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-080-5_12 · Cited by 6
Association of 5-HT1A Receptors with Affective Disorders
Soria-Fregozo, C., Vega, M. I. P., Rodríguez‐Landa, J. F., Germán-Ponciano, L. J., García-Ríos, R. I., & Mora-Pérez, A. (2017) · InTech eBooks · doi:10.5772/intechopen.68975 · Cited by 6
Alterations of Neurotransmitter Receptors in Schizophrenia: Evidence from Postmortem Studies
Kristiansen, L. V., Cowell, R. M., Biscaia, M., McCullumsmith, R. E., & Meador‐Woodruff, J. H. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_14 · Cited by 6
The serotonin2B receptor and neurochemical regulation in the brain
Spampinato, U., Cathala, A., & Devroye, C. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00007-4 · Cited by 6
Dai, X., Zhou, L.-Y., Cao, J.-X., Zhang, Y.-Q., Yang, F., Wang, A.-Q., Wei, W., & Yang, S. (2018) · PubMed Central · doi:10.6620/zs.2018.57-35 · Cited by 6
Laurent, L., Jean, A., Manrique, C., Najimi, M., Chigr, F., & Compan, V. (2012) · Neuromethods · doi:10.1007/978-1-62703-104-2_19 · Cited by 6
Brain Neurotransmitters and Eating Disorders
Murray, S. M., & Kaye, W. H. (2023) · Springer eBooks · doi:10.1007/978-3-030-97416-9_46-1 · Cited by 5
The role of the prefrontal cortex in modulating aggression in humans and rodents
Li, X., Xiong, L., & Li, Y. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115285 · Cited by 5
Serotonin circuits act cooperatively with pathophysiology of opioid use disorder
Arakawa, H., & Akihiko, O. (2024) · Addiction Neuroscience · doi:10.1016/j.addicn.2024.100187 · Cited by 5
Edem, E. E., Okhonmina, U., Nebo, K. E., Akinluyi, E. T., Ikuelogbon, D. A., Fafure, A. A., Olabiyi, A. A., & Adedokun, M. A. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00589-1 · Cited by 5
“However, the metabotropic 5-HTiA receptors are the most predominant in the PFC (Santana et al. 1991) and are our focus in this study.”
BackgroundSun, Y., Chebolu, S., Skegrud, S., Kamali, S., & Darmani, N. A. (2023) · BMC Neuroscience · doi:10.1186/s12868-022-00766-0 · Cited by 5
Puzerey, P. A., Kodama, N. X., & Galán, R. F. (2015) · Journal of Neurophysiology · doi:10.1152/jn.00996.2014 · Cited by 5
“…5-HT receptors across regions, laminae, and cell types of the cortex (AmargosBosch et al. 2004; Blue et al. 1988; Jakab and Goldman-Rakic 2000; Santana et al. 2004; Weber and Andrade 2010) and microcircuit-specific and context-dependent activation of distinct receptors on neurons expressing…”
BackgroundFuster, J. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-407815-4.00003-9 · Cited by 5
Li, L.-F., Zhang, L.-Z., He, Z.-X., Zhang, Y.-T., Ma, H., Xun, Y.-F., Yuan, W., Hou, W.-J., Li, Y.-T., Lv, Z.-J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.21.307280 · Cited by 5
Gacoin, M., & Hamed, S. B. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1103999 · Cited by 4
“, 2007), indirectly affecting the GABA levels in the brain (Santana et al., 2004; Beshara et al., 2016).”
BackgroundNiitani, K., Nishida, R., Futami, Y., Nishitani, N., Deyama, S., & Kaneda, K. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110181 · Cited by 4
Cao, J. J., Liu, J., Zhang, Q.-J., Wang, T., Wang, S., Han, L., & Li, Q. (2007) · Neuroscience Bulletin · doi:10.1007/s12264-007-0047-5 · Cited by 4
“Recent data indicate that 50-60% of the pyramidal neurons and 20-30% of the GABAergic interneurons in mPFC express 5-HT1A receptors[31].”
Chapter 6.3 The use of brain microdialysis in antidepressant drug research
Artigas, F., & Adell, A. (2006) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(06)16028-2 · Cited by 4
Cellular effects of serotonin in the CNS
Andrade, R., & Haj‐Dahmane, S. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00015-3 · Cited by 4
Borsetti, V., & Ernesto, P. (2008) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 4
Clinical pharmacology of ayahuasca: potential applications and future considerations
Guerra, L. T. L., Dias, I. C. D. S., Hallak, J. E. C., & SANTOS, R. G. D. (2025) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2025.2577726 · Cited by 3
“Cortical interneurons can also express 5HT receptors, suggesting that 5HT agonists can also modulate GABAergic signaling [27,28].”
Bombardi, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-70474-6_4 · Cited by 3
Metadata
- Authors
- Santana, N.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Corresponding author
- Santana, N.
- ORCID
- Santana, N.
- Venue
- Cerebral Cortex
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-04-27
- Volume
- 14
- Issue
- 10
- Pages
- 1100-1109
- ISSN
- 1047-3211 (ISSN-L)
- 1460-2199
- OpenAlex
- W2156868152
- Cited by
- 486
- References
- 80
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 29 · 2023: 19 · 2022: 11 · 2021: 34 · 2020: 20 · 2019: 14 · 2018: 21 · 2017: 23 · 2016: 23 · 2015: 30 · 2014: 28 · 2013: 28 · 2012: 19
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cerebral Cortex (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- 5-HT1A receptor, 5-HT2A receptor, prefrontal cortex, pyramidal neurons, GABAergic interneurons, glutamatergic neurons, receptor colocalization, atypical antipsychotics, prelimbic cortex, cortical layers
- MeSH terms
- Animals, gamma-Aminobutyric Acid, Gene Expression Regulation, Male, Neurons, Rats, Wistar, Prefrontal Cortex, Pyramidal Cells, Receptor, Serotonin, 5-HT1A, Receptor, Serotonin, 5-HT2A, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.